393 related articles for article (PubMed ID: 29444269)
1. Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients.
Fichtner A; Süsal C; Schröder C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Dragun D; Tönshoff B
Nephrol Dial Transplant; 2018 Jun; 33(6):1065-1072. PubMed ID: 29444269
[TBL] [Abstract][Full Text] [Related]
2. Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients.
Fichtner A; Süsal C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Opelz G; Tönshoff B
Pediatr Nephrol; 2016 Jul; 31(7):1157-66. PubMed ID: 26928311
[TBL] [Abstract][Full Text] [Related]
3. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
Liu C; Kang ZY; Yin Z; Xiao Y; Liu W; Zhao Y; Li DH
Transpl Immunol; 2022 Oct; 74():101674. PubMed ID: 35901953
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
Min JW; Lee H; Choi BS; Park CW; Yang CW; Kim YS; Choi YJ; Oh EJ; Chung BH
Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
[TBL] [Abstract][Full Text] [Related]
5. Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection.
Crespo M; Llinàs-Mallol L; Redondo-Pachón D; Butler C; Gimeno J; Pérez-Sáez MJ; Burballa C; Buxeda A; Arias-Cabrales C; Folgueiras M; Sanz-Ureña S; Valenzuela NM; Reed EF; Pascual J
Front Immunol; 2021; 12():703457. PubMed ID: 34305943
[TBL] [Abstract][Full Text] [Related]
6. Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients.
Fichtner A; Süsal C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Dragun D; Tönshoff B
Pediatr Nephrol; 2021 Aug; 36(8):2473-2484. PubMed ID: 33759004
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
[TBL] [Abstract][Full Text] [Related]
8. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Nephrology (Carlton); 2019 Mar; 24(3):347-356. PubMed ID: 29451342
[TBL] [Abstract][Full Text] [Related]
9. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
[TBL] [Abstract][Full Text] [Related]
10. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
[TBL] [Abstract][Full Text] [Related]
11. The early impact of preformed angiotensin II type 1 receptor antibodies on graft function in a low immunological risk cohort of kidney transplant recipients.
Sorohan BM; Ismail G; Berechet A; Obrișcă B; Constantinescu I; Mărunțelu I; Tacu D; Baston C; Sinescu I
Transpl Immunol; 2021 Jun; 66():101389. PubMed ID: 33838295
[TBL] [Abstract][Full Text] [Related]
12. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
[TBL] [Abstract][Full Text] [Related]
13. Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
Gold A; Fichtner A; Choukair D; Schmitt CP; Süsal C; Dragun D; Tönshoff B
Pediatr Nephrol; 2021 Mar; 36(3):725-729. PubMed ID: 33355703
[TBL] [Abstract][Full Text] [Related]
14. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies.
Philogene MC; Bagnasco S; Kraus ES; Montgomery RA; Dragun D; Leffell MS; Zachary AA; Jackson AM
Transplantation; 2017 Mar; 101(3):608-615. PubMed ID: 27222934
[TBL] [Abstract][Full Text] [Related]
15. Association of positive pre-transplant angiotensin II type 1 receptor antibodies with clinical outcomes in lung transplant recipients.
Son BS; Lee HJ; Cho WH; So MW; Park JM; Yeo HJ
Transpl Immunol; 2023 Oct; 80():101901. PubMed ID: 37442212
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of AT1R antibody (AT1R-Ab) among Malaysian multi-ethnic population.
Jalalonmuhali M; Caroll R; Deayton S; Emery T; Humphreys I; Lim SJ; Lim SK; Coates T
Hum Immunol; 2020 Dec; 81(12):679-684. PubMed ID: 32736900
[TBL] [Abstract][Full Text] [Related]
17. Rejection and graft outcomes in kidney transplant recipients with and without angiotensin II receptor type 1 antibodies.
Aljishi M; Isbel NM; Jegatheesan D; Johnson DW; Cho Y; Campbell SB; Hawley CM; Thornton A; Gillis D; Johnstone K
Transpl Immunol; 2023 Feb; 76():101756. PubMed ID: 36460263
[TBL] [Abstract][Full Text] [Related]
18. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.
Taniguchi M; Rebellato LM; Cai J; Hopfield J; Briley KP; Haisch CE; Catrou PG; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
Am J Transplant; 2013 Oct; 13(10):2577-89. PubMed ID: 23941128
[TBL] [Abstract][Full Text] [Related]
19. Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome.
Reinsmoen NL; Lai CH; Mirocha J; Cao K; Ong G; Naim M; Wang Q; Haas M; Rafiei M; Czer L; Patel J; Kobashigawa J
Transplantation; 2014 Mar; 97(5):595-601. PubMed ID: 24162250
[TBL] [Abstract][Full Text] [Related]
20. Pre-transplant AT1R antibodies and long-term outcomes in kidney transplant recipients with a functioning graft for more than 5 years.
Aziz F; Jung-Hynes B; Parajuli S; Redfield RR; Astor BC; Mandelbrot D; Hidalgo L; Djamali A
Clin Nephrol; 2020 Nov; 94(5):245-251. PubMed ID: 32870149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
